More China Public Hospitals Seek Private Funds
This article was originally published in PharmAsia News
Beijing Shuntiande TCM Hospital, which comes under the State Administration of Traditional Chinese Medicine, recently listed on the China Beijing Equity Exchange, transferring 99 percent of its equity. The event shows public hospitals are gradually opening up to community funding. An official involved in the project revealed that many domestic and foreign companies have shown an interest as such an option is scarce relative to other projects. Currently, a few public hospitals are moving toward market-oriented development. For instance, Number One People's Hospital and Children's Hospital in Kunming are inviting investors for their respective new construction projects, which will adopt a joint stock system. Analysts believe that China's health care market needs a diversified medical treatment model that combines public welfare, community service and business. (Click here for more - Chinese Language)
You may also be interested in...
US FDA looks to post-marketing studies to address elements of the NDA that were not central to its initial swift approval as the first COVID-19 therapy, including pediatric use and the interaction of hepatotoxicity and dose duration.
But advisory committee members caution against including pediatric population in COVID-19 vaccine trials, and one member expresses concern that Pfizer is testing those as young as 12 years of age. Agency is in discussions with product sponsors about enrollment of adolescents.
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.